Pallas Capital Advisors LLC Invests $6.84 Million in Danaher Corporation $DHR

Pallas Capital Advisors LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 9,499 shares of the conglomerate’s stock, valued at approximately $6,840,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. State Street Corp lifted its holdings in shares of Danaher by 1.7% during the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after purchasing an additional 472,608 shares during the last quarter. Capital International Investors boosted its position in shares of Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. Price T Rowe Associates Inc. MD grew its stake in Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares during the last quarter. Wellington Management Group LLP increased its position in Danaher by 11.2% during the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after buying an additional 1,517,904 shares in the last quarter. Finally, Norges Bank acquired a new position in Danaher during the 4th quarter valued at about $2,177,106,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.0%

Shares of DHR stock opened at $202.44 on Tuesday. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm has a market capitalization of $142.31 billion, a PE ratio of 35.96, a P/E/G ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock’s 50-day simple moving average is $193.52 and its 200-day simple moving average is $192.67.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.77 earnings per share. Equities analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Analysts Set New Price Targets

DHR has been the topic of a number of research analyst reports. Piper Sandler began coverage on Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. UBS Group decreased their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Citigroup started coverage on shares of Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. Argus dropped their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. Finally, DZ Bank assumed coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target for the company. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.